Pharmaceutical preparations, namely, cell therapy to treat diseases associated with inflammation such as autoimmune and neurodegenerative diseases, and biologic medications that reduce effector cells involved in diseases associated with inflammation, particularly, autoimmune and neurodegenerative diseases